Quality Assurance Sampling Plans in US Stockpiles for Personal Protective Equipment: A Computer Simulation to Examine Degradation Rates.
Countermeasures
Personal protective equipment
Stockpile
Journal
Health security
ISSN: 2326-5108
Titre abrégé: Health Secur
Pays: United States
ID NLM: 101654694
Informations de publication
Date de publication:
Historique:
entrez:
22
8
2019
pubmed:
23
8
2019
medline:
19
5
2020
Statut:
ppublish
Résumé
Medical countermeasure stockpiles in the United States are designed to support healthcare workers and the public during public health emergencies; they include supplies of personal protective equipment (PPE). As part of typical PPE manufacturing processes, appropriate test methods are used to ensure that the devices provide adequate protective performance. At the time of manufacture, performance is often measured and weighed against an objective standard of quality, resulting in a pass or fail attribute being assigned to individual PPE items and thence to production lots. Incorporating periodic performance testing for stockpiled PPE can ensure that they maintain their protective qualities and integrity over time while in storage. There is an absence of guidance regarding how to design quality assurance programs for stockpiled PPE. The applicability of the Lot Quality Assurance Sampling (LQAS) approach to stockpiled PPE was examined in a previous study that compared and contrasted different sample sizes in recovering the true percentage of defective units in large lots in the LQAS framework. The current study carries this line of inquiry forward by integrating PPE degradation over time and comparing different sampling time intervals in recovering the true underlying degradation rate. The results suggest that product degradation is more easily detected when tested at shorter time intervals and for higher degradation rates. They further suggest that sampling interval groupings can be made based on the proficiency with which they recover the true underlying degradation rate.
Identifiants
pubmed: 31433277
doi: 10.1089/hs.2019.0042
pmc: PMC6823634
mid: NIHMS1054665
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
324-333Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Références
Clin Infect Dis. 2015 May 1;60 Suppl 1:S42-51
pubmed: 25878300
Am J Infect Control. 2009 Nov;37(9):703-7
pubmed: 19748157
Am J Infect Control. 2017 Mar 1;45(3):272-277
pubmed: 27916341
Health Secur. 2018 Mar/Apr;16(2):119-126
pubmed: 29570355
Acad Emerg Med. 2006 Nov;13(11):1198-203
pubmed: 16885400
J Int Soc Respir Prot. 2017;34(2):69-80
pubmed: 30364841
Disaster Manag Response. 2003 Jul-Sep;1(3):68-70
pubmed: 12888743
J Microsc. 2007 Jan;225(Pt 1):72-9
pubmed: 17286696
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1011-6
pubmed: 20731598
Am J Public Health. 2018 Nov;108(11):1469-1472
pubmed: 30252525
Health Secur. 2019 Mar/Apr;17(2):140-151
pubmed: 31009257
Emerg Infect Dis. 2009 Jun;15(6):e1
pubmed: 21970033
BMC Public Health. 2015 Sep 03;15:847
pubmed: 26335570
Am J Infect Control. 2009 Jun;37(5):381-386
pubmed: 19188003